erythromycin has been researched along with paraquat in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Holbrook, MA; Menninger, JR | 1 |
Du, Y; He, Q | 2 |
7 other study(ies) available for erythromycin and paraquat
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Erythromycin slows aging of Saccharomyces cerevisiae.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Erythromycin; Gentamicins; Herbicides; Models, Biological; Paraquat; Saccharomyces cerevisiae | 2002 |
[The mechanism of alleviation of paraquat induced vascular endothelial permeability by erythromycin through adenosine 3'5'-cyclic monophosphate pathway].
Topics: Capillary Permeability; Cells, Cultured; Cyclic AMP; Endothelial Cells; Endothelium, Vascular; Erythromycin; Humans; Paraquat; Umbilical Veins | 2009 |
[Molecular mechanism of erythromycin in the improvement of paraquat-damaged vascular endothelial cell barrier function].
Topics: Cell Membrane Permeability; Cyclic AMP; Endothelial Cells; Erythromycin; Humans; Paraquat; Umbilical Veins | 2009 |